124 related articles for article (PubMed ID: 38183417)
1. Reduced human leukocyte antigen mismatching is associated with more favourable outcomes after unrelated donor haematopoietic stem cell transplantation.
Valatkaite-Rakstiene B; Cekauskiene R; Zvirblis T; Jakubauskas A
Int J Immunogenet; 2024 Apr; 51(2):63-71. PubMed ID: 38183417
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effect of major histocompatibility complex class I-related chain a and human leukocyte antigen-DPB1 mismatches in association with acute graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation.
Askar M; Sun Y; Rybicki L; Zhang A; Thomas D; Kalaycio M; Pohlman B; Dean R; Duong H; Hanna R; Maciejewski J; Majhail NS; Bolwell B; Sobecks R
Biol Blood Marrow Transplant; 2014 Nov; 20(11):1835-40. PubMed ID: 25064744
[TBL] [Abstract][Full Text] [Related]
3. Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study.
Fleischhauer K; Shaw BE; Gooley T; Malkki M; Bardy P; Bignon JD; Dubois V; Horowitz MM; Madrigal JA; Morishima Y; Oudshoorn M; Ringden O; Spellman S; Velardi A; Zino E; Petersdorf EW;
Lancet Oncol; 2012 Apr; 13(4):366-74. PubMed ID: 22340965
[TBL] [Abstract][Full Text] [Related]
4. Impact of HLA-DPB1 Matching on Outcome of Unrelated Transplant for Hematologic Malignant Diseases: A Systematic Review and Meta-analysis.
Wang Y; Xu S; Fang P
Transplant Proc; 2019; 51(6):1982-1989. PubMed ID: 31399180
[TBL] [Abstract][Full Text] [Related]
5. The Human Leukocyte Antigen-DPB1 Degree of Compatibility Is Determined by Its Expression Level and Mismatch Permissiveness: A German Multicenter Analysis.
Mytilineos D; Tsamadou C; Neuchel C; Platzbecker U; Bunjes D; Schub N; Wagner-Drouet E; Wulf G; Kröger N; Murawski N; Einsele H; Schaefer-Eckart K; Freitag S; Casper J; Kaufmann M; Dürholt M; Hertenstein B; Klein S; Ringhoffer M; Mueller CR; Frank S; Schrezenmeier H; Fuerst D; Mytilineos J
Front Immunol; 2020; 11():614976. PubMed ID: 33569061
[TBL] [Abstract][Full Text] [Related]
6. HLA Association with hematopoietic stem cell transplantation outcome: the number of mismatches at HLA-A, -B, -C, -DRB1, or -DQB1 is strongly associated with overall survival.
Loiseau P; Busson M; Balere ML; Dormoy A; Bignon JD; Gagne K; Gebuhrer L; Dubois V; Jollet I; Bois M; Perrier P; Masson D; Moine A; Absi L; Reviron D; Lepage V; Tamouza R; Toubert A; Marry E; Chir Z; Jouet JP; Blaise D; Charron D; Raffoux C
Biol Blood Marrow Transplant; 2007 Aug; 13(8):965-74. PubMed ID: 17640601
[TBL] [Abstract][Full Text] [Related]
7. HLA-DRB3/4/5 mismatches are associated with increased risk of acute GVHD in 10/10 matched unrelated donor hematopoietic cell transplantation.
Ducreux S; Dubois V; Amokrane K; Yakoub-Agha I; Labalette M; Michallet M; Rubio MT; Kennel A; Forcade E; Lafarge X; Bulabois CE; Masson D; Daguindau E; Devys A; Moalic V; Quelvennec E; Boudifa A; Picard C; Van Endert P; de Matteis M; Delbos F; Filloux M; Pedron B; Renac V; Hau F; Bonneau J; Parissiadis A; Fort M; Dormoy A; Maillard N; Jollet I; Chevallier P; Cesbron A; Bay JO; Quainon F; Garnier F; Socié G; Loiseau P; Porcher R; Peffault de Latour R;
Am J Hematol; 2018 May; ():. PubMed ID: 29726580
[TBL] [Abstract][Full Text] [Related]
8. Dynamic Detection of Anti-Human Leukocyte Antigen (HLA) Antibodies but not HLA-DP Loci Mismatches Can Predict Acute Graft-versus-Host Disease and Overall Survival in HLA 12/12-Matched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies.
Pan Z; Yuan X; Li Y; Wu X; Zhu W; Bao X; Zhao Q; He J
Biol Blood Marrow Transplant; 2016 Jan; 22(1):86-95. PubMed ID: 26283096
[TBL] [Abstract][Full Text] [Related]
9. Sequence Variations Within
Suzuki S; Morishima S; Murata M; Tanaka M; Shigenari A; Ito S; Kanga U; Kulski JK; Morishima Y; Shiina T
Front Immunol; 2022; 13():938206. PubMed ID: 35935961
[TBL] [Abstract][Full Text] [Related]
10. Effect of nonpermissive HLA-DPB1 mismatches after unrelated allogeneic transplantation with in vivo T-cell depletion.
Oran B; Saliba RM; Carmazzi Y; de Lima M; Rondon G; Ahmed S; Alousi A; Andersson BS; Anderlini P; Alvarez M; Bashir Q; Ciurea S; Fernandez-Vina M; Hosing C; Kebriaei P; Korbling M; Cano P; Khouri I; Marin D; Nieto Y; Olson A; Popat U; Rezvani K; Qazilbash M; Shpall EJ; Champlin RE; Cao K
Blood; 2018 Mar; 131(11):1248-1257. PubMed ID: 29386198
[TBL] [Abstract][Full Text] [Related]
11. The Case for High Resolution Extended 6-Loci HLA Typing for Identifying Related Donors in the Indian Subcontinent.
Agarwal RK; Kumari A; Sedai A; Parmar L; Dhanya R; Faulkner L
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1592-1596. PubMed ID: 28603069
[TBL] [Abstract][Full Text] [Related]
12. HLA-DPB1 matching in unrelated hematopoietic stem cell transplantation program contributes to a higher incidence of disease relapse.
Burek Kamenaric M; Maskalan M; Grubic Z; Mikulic M; Serventi Seiwerth R; Durakovic N; Vrhovac R; Stingl Jankovic K; Zunec R
Hum Immunol; 2017 Nov; 78(11-12):665-671. PubMed ID: 28887054
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes of HLA-DPB1 mismatches in 10/10 HLA-matched unrelated donor-recipient pairs undergoing allogeneic stem cell transplant.
Moyer AM; Hashmi SK; Kroning CM; Kremers WK; De Goey SR; Patnaik M; Litzow M; Gastineau DA; Hogan WJ; Jacob EK; Kreuter JD; Wakefield LL; Gandhi MJ
Eur J Haematol; 2017 Sep; 99(3):275-282. PubMed ID: 28632323
[TBL] [Abstract][Full Text] [Related]
14. Molecular disparity of HLA-DPB1 is associated with the development of subsequent solid cancer after allogeneic hematopoietic stem cell transplantation.
Zou J; Kongtim P; Oran B; Srour SA; Greenbaum U; Carmazzi Y; Rondon G; Ciurea SO; Ma Q; Shpall EJ; Champlin RE; Cao K
Cancer; 2023 Apr; 129(8):1205-1216. PubMed ID: 36738229
[TBL] [Abstract][Full Text] [Related]
15. Refined HLA-DPB1 mismatch with molecular algorithms predicts outcomes in hematopoietic stem cell transplantation.
Zou J; Kongtim P; Oran B; Kosmoliaptsis V; Carmazzi Y; Ma J; Li L; Rondon G; Srour S; Copley HC; Partlow D; Ciurea SO; Greenbaum U; Ma Q; Shpall EJ; Champlin RE; Cao K
Haematologica; 2022 Apr; 107(4):844-856. PubMed ID: 34435482
[TBL] [Abstract][Full Text] [Related]
16. Triple-Drug Graft-versus-Host Disease Prophylaxis after HLA-Matched Unrelated Donor Nonmyeloablative Allogenic Hematopoietic Stem Cell Transplantation.
Wegener A; Andersen NS; Friis LS; Petersen SL; Schjødt I; Kornblit B; Sengeløv H; Gjærde LK
Transplant Cell Ther; 2023 Sep; 29(9):575.e1-575.e6. PubMed ID: 37301257
[TBL] [Abstract][Full Text] [Related]
17. IMPACT OF HLA-DPB1 MATCHING ON CLINICAL OUTCOMES AFTER HAPLOIDENTICAL-RELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION.
Jaime-Pérez JC; Cancela-Murrieta CO; Salazar-Cavazos L; Aguilar-Calderón PE; Salazar-Riojas R; Méndez-Ramírez N; Cantú-Rodríguez OG; Gutiérrez-Aguirre CH; Gómez-Almaguer D
Rev Invest Clin; 2020; 72(2):69-79. PubMed ID: 32284622
[TBL] [Abstract][Full Text] [Related]
18.
Tsamadou C; Engelhardt D; Platzbecker U; Sala E; Valerius T; Wagner-Drouet E; Wulf G; Kröger N; Murawski N; Einsele H; Schaefer-Eckart K; Freitag S; Casper J; Kaufmann M; Dürholt M; Hertenstein B; Klein S; Ringhoffer M; Frank S; Neuchel C; Schrezenmeier H; Mytilineos J; Fuerst D
Front Immunol; 2021; 12():771449. PubMed ID: 34970261
[TBL] [Abstract][Full Text] [Related]
19. Donor selection in a pediatric stem cell transplantation cohort using PIRCHE and HLA-DPB1 typing.
Stenger W; Künkele A; Niemann M; Todorova K; Pruß A; Schulte JH; Eggert A; Oevermann L
Pediatr Blood Cancer; 2020 Mar; 67(3):e28127. PubMed ID: 31850671
[TBL] [Abstract][Full Text] [Related]
20. Allelic HLA Matching and Pair Origin Are Favorable Prognostic Factors for Unrelated Hematopoietic Stem Cell Transplantation in Neoplastic Hematologic Diseases: An Italian Analysis by the Gruppo Italiano Trapianto di Cellule Staminali e Terapie Cellulari, Italian Bone Marrow Donor Registry, and Associazione Italiana di Immunogenetica e Biologia dei Trapianti.
Picardi A; Sacchi N; Miotti V; Lorentino F; Oldani E; Rambaldi A; Sessa M; Bruno B; Cerno M; Vago L; Bernasconi P; Arcese W; Benedetti F; Pioltelli P; Russo D; Farina L; Fagioli F; Guidi S; Saporiti G; Zallio F; Chiusolo P; Borghero C; Papalinetti G; La Rocca U; Milone G; Lamparelli T; Carella AM; Luppi M; Olivieri A; Martino M; Carluccio P; Celeghini I; Andreani M; Gallina AM; Patriarca F; Pollichieni S; Mammoliti S; Miccichè S; Mangione I; Ciceri F; Bonifazi F
Transplant Cell Ther; 2021 May; 27(5):406.e1-406.e11. PubMed ID: 33965179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
